Author:
Furtado Melissa,Frey Benicio N.,Green Sheryl M.
Abstract
Abstract
Background
To date, there is a significant lack of research validating clinical tools for early and accurate detection of anxiety disorders in perinatal populations. Intolerance of uncertainty was recently identified as a significant risk factor for postpartum anxiety symptoms and is a key trait of non-perinatal anxiety disorders. The present study aimed to validate the Intolerance of Uncertainty Scale (IUS) in a perinatal population and evaluate its use as a screening tool for anxiety disorders.
Methods
Psychiatric diagnoses were assessed in a sample of perinatal women (n = 198), in addition to completing a self-report battery of questionnaires. Psychometric properties including internal consistency and convergent and discriminant validity were assessed. Determination of an optimal clinical cut-off score was measured through a ROC analysis in which the area under the curve, sensitivity, specificity, as well as positive and negative predictive values were calculated.
Results
The IUS demonstrated excellent internal consistency (α = 0.95) and an optimal clinical cut-off score of 64 or greater was established, yielding a sensitivity of 89%. The IUS also demonstrated very good positive (79%) and negative (80%) predictive values.
Conclusions
These findings suggest that the IUS represents a clinically useful screening tool to be used as an aid for the early and accurate detection of perinatal anxiety.
Publisher
Springer Science and Business Media LLC
Subject
Obstetrics and Gynecology
Reference82 articles.
1. Remes O, Brayne C, van der Linde R, Lafortune L. A systematic review of reviews on the prevalence of anxiety disorders in adult populations. Brain Behav. 2016;6(7):e00497. https://doi.org/10.1002/brb3.497.
2. Baxter AJ, Vos T, Scott KM, Ferrari AJ, Whiteford HA. The global burden of anxiety disorders in 2010. Psychol Med. 2014;44(11):2363–74. https://doi.org/10.1017/S0033291713003243.
3. Whiteford HA, Degenhardt L, Rehm J, Baxter AJ, Ferrari AJ, Erskine HE, et al. Global burden of disease attributable to mental and substance use disorders: Findings from the Global Burden of Disease Study 2010. Lancet. 2013;382(9904):1575–86. https://doi.org/10.1016/S0140-6736(13)61611-6.
4. Chisholm D, Sweeny K, Sheehan P, Rasmussen B, Smith F, Cuijpers P, et al. Scaling-up treatment of depression and anxiety: A global return on investment analysis. Lancet Psychiat. 2016;3(5):415–24. https://doi.org/10.1016/S2215-0366(16)30024-4.
5. Unmet mental health care needs costing Canadian economy billions. The Conference Board of Canada; 2016. Available from: http://www.conferenceboard.ca/press/newsrelease/16-09-01/unmet_mental_health_care_needs_costing_canadian_economy_billions.aspx?&utm_source=Home&utm_medium=Banner&utm_campaign=Slide1
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献